(UroToday.com) The ASCO 2020 virtual education program featured a session on recent advances in nuclear medicine theranostics for cancer. As part of this session, Jonathan McConathy, MD, Ph.D., provided an introductory presentation to theranostics. The term ‘theranostic’ is derived from ‘therapeutic plus diagnostic’, which is a diagnostic test to stratify patients by likelihood to respond to […]
(UroToday.com) The ASCO 2020 Virtual Education Program featured a session highlighting molecular enrichment strategies in genitourinary cancer, including Bradley McGregor, MD, discussing biomarker-driven strategies for renal cell cancer. Dr. McGregor notes that there are prognostic biomarkers that identify patients more likely to have a particular outcome, and there are predictive biomarkers that predict a favorable or […]
(UroToday.com) The ASCO 2020 Virtual Education Program featured a session highlighting molecular enrichment strategies in genitourinary cancer, including Bradley McGregor, MD, discussing biomarker-driven strategies for renal cell cancer. Dr. McGregor notes that there are prognostic biomarkers that identify patients more likely to have a particular outcome, and there are predictive biomarkers that predict a favorable or […]
(UroToday.com) As part of the ASCO 2020 Virtual Education Program, David McConkey, PhD, chaired a session on molecular enrichment strategies in genitourinary cancer, specifically highlighting in his talk what exactly is in the molecular enrichment toolbox. Indeed, the landscape is rapidly changing for advanced disease, including (i) the vascular endothelial growth factor (VEGF) pathway and […]
(UroToday.com) As part of the ASCO 2020 Virtual Education Program, David McConkey, PhD, chaired a session on molecular enrichment strategies in genitourinary cancer, specifically highlighting in his talk what exactly is in the molecular enrichment toolbox. Indeed, the landscape is rapidly changing for advanced disease, including (i) the vascular endothelial growth factor (VEGF) pathway and […]
(UroToday.com) Dr. Alexander Wyatt, PhD, Vancouver Prostate Center, and the University of British Columbia, discussed deoxyribonucleic acid (DNA) correlates in bacille Calmette-Guerin (BCG) unresponsive high-risk non-muscle invasive bladder cancer (NMIBC). He discussed recent study findings exploring links between common genomic driver alternations and BCG unresponsiveness.
TAS-303, which selectively inhibits noradrenaline reuptake, was developed for treating stress urinary incontinence (SUI). The proximal urethra mainly comprises smooth muscle fibers in which α1 adrenergic receptors are abundant.
Mesh was a promising, minimally invasive, and ‘gold standard’ treatment for urinary stress incontinence. Time has shown that complications from these devices can happen early, or even several years, after mesh placement and can be catastrophic.
To develop risk predictive models of postpartum stress urinary incontinence (SUI) for both primiparous and multiparous women. From July 2016 to July 2017, 815 singleton pregnant women without incontinence before pregnancy who were 18 years or older and admitted to 2 hospitals in Shenzhen, China, were enrolled.
To estimate the impact on testosterone prescribing over 3 years following the 2015 tightening of Pharmaceutical Benefits Scheme (PBS) criteria. Analysis of testosterone prescribing data from PBS and private (non-PBS) sources between 2012 and 2018 covering 2015 change in PBS prescribing criteria.
